Vault-13

Boxer Capital Management, LLC

San Diego, CA · CIK 2018299 · 13F filing filed 2026-05-15

SEC-registered investment adviser since 2024 · limited liability company

As an employer

$761.7m reported value +66.7% vs Q4 2025
54positions
63.3%in top 10
13 new 13 added 3 reduced 4 sold out vs Q4 2025

Holdings, Q1 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 TANGO THERAPEUTICS INC COM TNGX TNGX 10,876,219 $227.5m29.87% 29.87% UnchangedShares held: Q2 2025 9.8m, Q3 2025 9.8m, Q4 2025 10.9m, Q1 2026 10.9m
2 KODIAK SCIENCES INC COM KOD KOD 1,361,000 $51.9m6.81% 6.81% AddedShares held: Q2 2025 750.0k, Q3 2025 750.0k, Q4 2025 1.1m, Q1 2026 1.4m +225.0k +225,000 19.8%
3 REVOLUTION MEDICINES INC COM RVMD RVMD 500,000 $48.6m6.38% 6.38% AddedShares held: Q2 2025 793.0k, Q3 2025 400.0k, Q4 2025 400.0k, Q1 2026 500.0k +100.0k +100,000 25.0%
4 KYMERA THERAPEUTICS INC COM KYMR KYMR 329,100 $27.4m3.60% 3.60% UnchangedShares held: Q2 2025 432.0k, Q3 2025 319.1k, Q4 2025 329.1k, Q1 2026 329.1k
5 CELCUITY INC COM CELC CELC 225,000 $25.7m3.37% 3.37% UnchangedShares held: Q2 2025 0, Q3 2025 90.0k, Q4 2025 225.0k, Q1 2026 225.0k
6 SURROZEN INC COM NEW SRZN SRZN 766,318 $22.3m2.93% 2.93% AddedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 416.1k, Q1 2026 766.3k +350.2k +350,168 84.1%
7 ABIVAX SA SPONSORED ADS ABVX ABVX 200,000 $22.3m2.92% 2.92% AddedShares held: Q2 2025 0, Q3 2025 120.0k, Q4 2025 125.0k, Q1 2026 200.0k +75.0k +75,000 60.0%
8 TERNS PHARMACEUTICALS INC COM COM 375,000 $19.8m2.60% 2.60% UnchangedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 375.0k, Q1 2026 375.0k
9 VAXCYTE INC COM PCVX PCVX 325,000 $18.9m2.48% 2.48% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 325.0k
10 CAPRICOR THERAPEUTICS INC COM NEW CAPR CAPR 590,000 $17.9m2.35% 2.35% AddedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 325.0k, Q1 2026 590.0k +265.0k +265,000 81.5%
11 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 170,000 $17.9m2.35% 2.35% UnchangedShares held: Q2 2025 60.0k, Q3 2025 110.0k, Q4 2025 170.0k, Q1 2026 170.0k
12 VIR BIOTECHNOLOGY INC COM VIR VIR 1,866,000 $16.7m2.20% 2.20% AddedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 625.0k, Q1 2026 1.9m +1.2m +1,241,000 198.6%
13 CORVUS PHARMACEUTICALS INC COM CRVS CRVS 1,100,000 $16.1m2.11% 2.11% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 1.1m
14 PRAXIS PRECISION MEDICINES I COM NEW PRAX PRAX 46,457 $15.0m1.97% 1.97% UnchangedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 46.5k, Q1 2026 46.5k
15 PTC THERAPEUTICS INC COM PTCT PTCT 200,000 $13.6m1.79% 1.79% UnchangedShares held: Q2 2025 0, Q3 2025 200.0k, Q4 2025 200.0k, Q1 2026 200.0k
16 PRECIGEN INC COM PGEN PGEN 3,500,000 $13.5m1.78% 1.78% AddedShares held: Q2 2025 0, Q3 2025 850.0k, Q4 2025 1.4m, Q1 2026 3.5m +2.1m +2,125,000 154.6%
17 DEFINIUM THERAPEUTICS INC COM SHS DFTX DFTX 598,500 $11.3m1.49% 1.49% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 598.5k
18 AMYLYX PHARMACEUTICALS INC COM AMLX AMLX 800,000 $11.1m1.46% 1.46% UnchangedShares held: Q2 2025 1.2m, Q3 2025 900.0k, Q4 2025 800.0k, Q1 2026 800.0k
19 UNIQURE NV SHS QURE QURE 662,000 $10.8m1.42% 1.42% AddedShares held: Q2 2025 899.5k, Q3 2025 800.0k, Q4 2025 290.0k, Q1 2026 662.0k +372.0k +372,000 128.3%
20 OPUS GENETICS INC COM IRD IRD 2,250,000 $10.2m1.34% 1.34% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 2.2m
21 CORCEPT THERAPEUTICS INC COM CORT CORT 250,000 $10.1m1.32% 1.32% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 250.0k
22 UROGEN PHARMA LTD COM URGN URGN 500,000 $9.0m1.18% 1.18% UnchangedShares held: Q2 2025 575.0k, Q3 2025 575.0k, Q4 2025 500.0k, Q1 2026 500.0k
23 REPLIMUNE GROUP INC COM REPL REPL 1,175,000 $9.0m1.18% 1.18% AddedShares held: Q2 2025 2.2m, Q3 2025 1.1m, Q4 2025 750.0k, Q1 2026 1.2m +425.0k +425,000 56.7%
24 COGENT BIOSCIENCES INC COM COGT COGT 225,000 $8.7m1.14% 1.14% UnchangedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 225.0k, Q1 2026 225.0k
25 PALISADE BIO INC COM PALI PALI 4,799,875 $8.4m1.10% 1.10% UnchangedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 4.8m, Q1 2026 4.8m
26 CRESCENT BIOPHARMA INC. COM COM 453,686 $8.3m1.09% 1.09% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 453.7k
27 SOLENO THERAPEUTICS INC COM SLNO SLNO 200,000 $6.7m0.88% 0.88% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 200.0k
28 ALLOGENE THERAPEUTICS INC COM ALLO ALLO 2,725,000 $6.6m0.87% 0.87% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 2.7m
29 CYTOKINETICS INC COM NEW CYTK CYTK 100,000 $6.6m0.87% 0.87% UnchangedShares held: Q2 2025 0, Q3 2025 200.0k, Q4 2025 100.0k, Q1 2026 100.0k
30 CONTINEUM THERAPEUTICS INC CL A CTNM CTNM 494,000 $6.5m0.85% 0.85% UnchangedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 494.0k, Q1 2026 494.0k
31 APOGEE THERAPEUTICS INC COM COM 70,000 $5.9m0.77% 0.77% UnchangedShares held: Q2 2025 0, Q3 2025 50.0k, Q4 2025 70.0k, Q1 2026 70.0k
32 RELMADA THERAPEUTICS INC COM RLMD RLMD 842,106 $5.9m0.77% 0.77% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 842.1k
33 ZURA BIO LTD CLASS A ORD SHS ZURA ZURA 900,000 $5.4m0.70% 0.70% AddedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 50.0k, Q1 2026 900.0k +850.0k +850,000 1700.0%
34 MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD MLTX MLTX 275,000 $5.1m0.67% 0.67% UnchangedShares held: Q2 2025 0, Q3 2025 250.0k, Q4 2025 275.0k, Q1 2026 275.0k
35 AVALO THERAPEUTICS INC COM NEW AVTX AVTX 300,000 $4.5m0.59% 0.59% AddedShares held: Q2 2025 0, Q3 2025 125.0k, Q4 2025 275.0k, Q1 2026 300.0k +25.0k +25,000 9.1%
36 INOVIO PHARMACEUTICALS INC COM SHS INO INO 2,370,122 $4.1m0.54% 0.54% ReducedShares held: Q2 2025 0, Q3 2025 2.3m, Q4 2025 2.4m, Q1 2026 2.4m -50.0k -50,000 -2.1%
37 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 75,000 $3.6m0.47% 0.47% UnchangedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 75.0k, Q1 2026 75.0k
38 SAREPTA THERAPEUTICS INC COM SRPT SRPT 150,000 $3.3m0.43% 0.43% UnchangedShares held: Q2 2025 25.0k, Q3 2025 250.0k, Q4 2025 150.0k, Q1 2026 150.0k
39 CYBIN INC COM NEW COM NEW 640,000 $3.1m0.40% 0.40% ReducedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 715.0k, Q1 2026 640.0k -75.0k -75,000 -10.5%
40 OCULAR THERAPEUTIX INC COM OCUL OCUL 350,000 $3.0m0.39% 0.39% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 350.0k
41 AN2 THERAPEUTICS INC COM ANTX ANTX 749,035 $2.6m0.34% 0.34% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 749.0k
42 CLENE INC COM NEW CLNN CLNN 477,515 $2.4m0.31% 0.31% AddedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 199.7k, Q1 2026 477.5k +277.8k +277,778 139.1%
43 ORIC PHARMACEUTICALS INC COM ORIC ORIC 176,500 $2.2m0.29% 0.29% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 176.5k
44 SOLID BIOSCIENCES INC COM NEW SLDB SLDB 300,000 $2.2m0.28% 0.28% UnchangedShares held: Q2 2025 0, Q3 2025 600.0k, Q4 2025 300.0k, Q1 2026 300.0k
45 INVIVYD INC COM IVVD IVVD 1,500,000 $1.9m0.26% 0.26% UnchangedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 1.5m, Q1 2026 1.5m
46 LB PHARMACEUTICALS INC COM SHS LBRX LBRX 70,000 $1.7m0.23% 0.23% UnchangedShares held: Q2 2025 0, Q3 2025 70.0k, Q4 2025 70.0k, Q1 2026 70.0k
47 KARYOPHARM THERAPEUTICS INC COM NEW KPTI KPTI 302,536 $1.7m0.22% 0.22% AddedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 252.5k, Q1 2026 302.5k +50.0k +50,000 19.8%
48 NURIX THERAPEUTICS INC COM NRIX NRIX 100,000 $1.6m0.20% 0.20% UnchangedShares held: Q2 2025 175.0k, Q3 2025 175.0k, Q4 2025 100.0k, Q1 2026 100.0k
49 UPSTREAM BIO INC COM UPB UPB 150,000 $1.4m0.18% 0.18% UnchangedShares held: Q2 2025 0, Q3 2025 0, Q4 2025 150.0k, Q1 2026 150.0k
50 MILESTONE PHARMACEUTICALS IN COM MIST MIST 666,666 $793.3k0.10% 0.10% UnchangedShares held: Q2 2025 0, Q3 2025 666.7k, Q4 2025 666.7k, Q1 2026 666.7k
51 PEPGEN INC COM PEPG PEPG 272,892 $483.0k0.06% 0.06% ReducedShares held: Q2 2025 0, Q3 2025 250.0k, Q4 2025 373.9k, Q1 2026 272.9k -101.0k -101,000 -27.0%
52 KALVISTA PHARMACEUTICALS INC COM KALV KALV 20,400 $410.7k0.05% 0.05% UnchangedShares held: Q2 2025 93.4k, Q3 2025 20.4k, Q4 2025 20.4k, Q1 2026 20.4k
53 REGENXBIO INC COM RGNX RGNX 15,000 $125.7k0.02% 0.02% NewShares held: Q2 2025 0, Q3 2025 0, Q4 2025 0, Q1 2026 15.0k
54 SURROZEN INC *W EXP 08/01/203 *W EXP 08/01/203 66,666 $1.1k0.00% 0.00% UnchangedShares held: Q2 2025 66.7k, Q3 2025 66.7k, Q4 2025 66.7k, Q1 2026 66.7k

Sold out since Q4 2025

SecurityTickerShares held beforeValue then
CIDARA THERAPEUTICS INC CDTX CDTX 53,000 $11.7m53.0k shares
MIND MEDICINE MINDMED INC 598,500 $8.0m598.5k shares
CRESCENT BIOPHARMA INC. CBIO CBIO 453,686 $5.4m453.7k shares
NUVATION BIO INC NUVB.WS NUVB.WS 266,666 $88.0k266.7k shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
Q32 BIO INC QTTB · 13G · filed 2026-07-10 QTTB 13.3%≈ $40.1m new 13G 2026-07-10
SURROZEN INC SRZN · 13G · filed 2026-10-07 SRZN 11.6%≈ $35.3m +2.7 pts 13G 2026-10-07